Keywords: merck, co, re-submits, nda, arcoxia, drug, major

Merck & Co re-submits NDA for Arcoxia

Article | 05 January 2004

Print This

US drug major Merck & Co has re-submitted a New Drug Application for Arcoxia (etoricoxib) to the Food and Drug Administration, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in